By Nana O 
Los Angeles, CA – In a groundbreaking discovery poised to revolutionize the treatment of debilitating neurological conditions, researchers at Cedars-Sinai have identified a previously unknown biological repair mechanism within the central nervous system. This intricate process, detailed in the prestigious journal Nature, centers on a critical, yet often overlooked, role for astrocytes, the primary support cells in the brain and spinal cord. The findings hold immense promise for developing novel therapeutic strategies for spinal cord injuries, stroke, and neurodegenerative diseases such as multiple sclerosis.
The study, led by neuroscientist Joshua Burda, PhD, assistant professor of Biomedical Sciences and Neurology at Cedars-Sinai, has pinpointed a population of astrocytes located at a distance from injury sites that actively contribute to spinal cord repair. These specialized cells, dubbed "lesion-remote astrocytes" (LRAs), orchestrate a complex signaling cascade that mobilizes the immune system to efficiently clear cellular debris, a pivotal step in tissue healing.
"Astrocytes are critical responders to disease and disorders of the central nervous system—the brain and spinal cord," stated Dr. Burda. "We discovered that astrocytes far from the site of an injury actually help drive spinal cord repair. Our research also uncovered a mechanism used by these unique astrocytes to signal the immune system to clean up debris resulting from the injury, which is a critical step in the tissue-healing process."
This research not only identifies LRAs but also delineates distinct subtypes within this population, revealing for the first time how a specific subtype can sense damage from afar and initiate a cascade of events that foster recovery.
Understanding the Spinal Cord’s Response to Injury
The spinal cord, a vital conduit of information extending from the brain, is composed of gray matter, housing nerve cell bodies and astrocytes, and white matter, characterized by myelinated nerve fibers and astrocytes. Astrocytes are indispensable for maintaining the delicate environment required for precise neural signaling.
When the spinal cord sustains an injury, such as from trauma or disease, nerve fibers are disrupted, leading to significant functional deficits, including paralysis and loss of sensation. The resulting torn fibers break down into cellular debris. While inflammation is a natural response to injury in most tissues, its manifestation in the spinal cord is particularly challenging due to the extensive reach of nerve fibers. This can cause inflammation and secondary damage to spread far beyond the initial injury site, exacerbating the damage and hindering recovery.
Lesion-Remote Astrocytes: Orchestrating Immune Cleanup
Through rigorous experimentation with mouse models of spinal cord injury, the Cedars-Sinai team provided compelling evidence that LRAs are central players in promoting repair. Crucially, the study also revealed strong indications that this same reparative process is active in human spinal cord tissue.
A key finding of the research is the identification of a specific LRA subtype that produces the protein CCN1. This molecule acts as a crucial signaling agent, directing the activity of microglia, the resident immune cells of the central nervous system. Microglia are often described as the "garbage collectors" of the brain and spinal cord, responsible for engulfing and clearing cellular debris.
"One function of microglia is to serve as chief garbage collectors in the central nervous system," explained Dr. Burda. "After tissue damage, they eat up pieces of nerve fiber debris—which are very fatty and can cause them to get a kind of indigestion. Our experiments showed that astrocyte CCN1 signals the microglia to change their metabolism so they can better digest all that fat."
This enhanced digestive capacity of microglia, facilitated by astrocyte-derived CCN1, is believed to be instrumental in preventing the accumulation of toxic debris and mitigating prolonged inflammation. According to Dr. Burda, this improved debris removal may shed light on instances of partial, spontaneous recovery observed in some spinal cord injury patients. Conversely, when researchers experimentally eliminated astrocyte-derived CCN1, the healing process was significantly impaired.
"If we remove astrocyte CCN1, the microglia eat, but they don’t digest. They call in more microglia, which also eat but don’t digest," Dr. Burda elaborated. "Big clusters of debris-filled microglia form, heightening inflammation up and down the spinal cord. And when that happens, the tissue doesn’t repair as well." This highlights the delicate balance required for effective tissue repair and the critical role of LRAs in maintaining it.
Broader Implications for Neurological Diseases
The significance of this discovery extends beyond spinal cord injuries. When examining spinal cord samples from individuals diagnosed with multiple sclerosis (MS), a chronic autoimmune disease that affects the brain and spinal cord, the researchers observed the same CCN1-related repair process at play. This suggests that the fundamental repair principles elucidated in this study may be broadly applicable to a range of injuries and diseases affecting both the brain and spinal cord.
"The role of astrocytes in central nervous system healing is remarkably understudied," commented David Underhill, PhD, chair of the Department of Biomedical Sciences at Cedars-Sinai. "This work strongly suggests that lesion-remote astrocytes offer a viable path for limiting chronic inflammation, enhancing functionally meaningful regeneration, and promoting neurological recovery after brain and spinal cord injury and in disease."
The implications for conditions such as stroke, traumatic brain injury, and neurodegenerative disorders like Parkinson’s and Alzheimer’s disease are profound. These conditions often involve significant inflammation and cellular debris accumulation, processes that the newly identified LRA pathway appears to directly address.
A New Frontier in Therapeutic Development
Dr. Burda and his team are now actively pursuing strategies to therapeutically harness the CCN1 pathway to enhance spinal cord healing. This could involve developing drugs or gene therapies that mimic or stimulate CCN1 production, or finding ways to bolster the activity of LRAs. Furthermore, the team is investigating how astrocyte CCN1 might influence the progression of inflammatory neurodegenerative diseases and the aging process, which is often associated with increased neuroinflammation.
The research team at Cedars-Sinai involved in this seminal work includes Sarah McCallum, Keshav B. Suresh, Timothy S. Islam, Manish K. Tripathi, Ann W. Saustad, Oksana Shelest, Aditya Patil, David Lee, Brandon Kwon, Katherine Leitholf, Inga Yenokian, Sophia E. Shaka, Jasmine Plummer, Vinicius F. Calsavara, and Simon R.V. Knott.
Additional contributions came from researchers Connor H. Beveridge, Palak Manchandra, Caitlin E. Randolph, Gordon P. Meares, Ranjan Dutta, Riki Kawaguchi, and Gaurav Chopra.
Funding and Support
This extensive research was made possible through significant funding from various national and international bodies dedicated to advancing medical science. Key financial support was provided by the U.S. National Institutes of Health (NIH) through grants 5R01NS128094, R00NS105915, K99NS105915 (to J.E.B.), F31NS129372 (to K.S.), K99AG084864 (S.M.), R35 NS097303 and R01 NS123532 (RD), R01MH128866, U18TR004146, P30 CA023168, and the ASPIRE Challenge and Reduction-to-Practice award (to G.C.).
Further support was received from the Paralyzed Veterans Research Foundation of America (to J.E.B.), Wings for Life (to J.E.B.), and Cedars-Sinai Center for Neuroscience and Medicine Postdoctoral Fellowship (to S.M.). The American Academy of Neurology also provided a Neuroscience Research Fellowship (to S.M.), as did the California Institute for Regenerative Medicine with a Postdoctoral Scholarship (to S.M.). The United States Department of Defense USAMRAA award W81XWH2010665, through the Peer Reviewed Alzheimer’s Research Program, also contributed funding (to G.C.). The Arnold O. Beckman Postdoctoral Fellowship supported C.E.R., and the Purdue University Center for Cancer Research, funded by NIH grant P30 CA023168, was also acknowledged.
This multifaceted support underscores the collaborative and critical nature of this research in addressing some of the most challenging health issues of our time. The identification of lesion-remote astrocytes and their role in orchestrating debris clearance represents a significant leap forward in our understanding of neural repair and opens promising avenues for future therapeutic interventions.